8-K
Current Report
Vistagen Therapeutics, Inc. Filed Acc 0001628280-26-068627
Exit or restructuring costs · Other events
- Item 2.05 Costs associated with exit or disposal activities
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading vtgn-20261026.htm…